Satoh M, Inagawa H, Minagawa H, Kajikawa T, Oshima H, Abe S, Yamazaki M, Mizuno D
J Biol Response Mod. 1986 Apr;5(2):140-7.
C3H/He mice were immunized i.v. with sheep red blood cells (SRBC), and then the effect of i.v. challenge with SRBC on the priming of endogenous production of tumor necrosis factor (TNF) was investigated. Mice were immunized i.v. with 10(8) SRBC/mouse, and their serum TNF activity, triggered by 3 micrograms lipopolysaccharide (LPS) per mouse, was assayed by an in vitro cytotoxicity test using L-929 cells. Anti-SRBC antibodies were induced maximally in 2 weeks, but the acquired immunity did not affect TNF triggering. However, 9-10 weeks after the primary challenge, when there was still a relatively high antibody titer in the serum, i.v. rechallenge with 10(8) SRBC/mouse transiently enhanced the TNF activity triggered by LPS to about 10 times that in normal control mice. This priming effect of SRBC challenge was antigen specific, because challenge with horse red blood cells (HRBC) had no effect. SRBC opsonized with anti-treated with anti-SRBC antiserum or sonicated SRBC had no effect. These findings suggest two ways of facilitating the triggering of endogenous TNF production: booster challenge of immunized animals with the corresponding antigens makes them ready for TNF triggering, and direct injection of immune complexes, even into normal animals, makes them ready for triggering of TNF. The possible application of these findings for inducing endogenous TNF production in human cancer patients by use of immune complexes is discussed.
用绵羊红细胞(SRBC)对C3H/He小鼠进行静脉免疫,然后研究静脉注射SRBC对肿瘤坏死因子(TNF)内源性产生启动作用的影响。用每只小鼠10⁸个SRBC进行静脉免疫,通过使用L-929细胞的体外细胞毒性试验测定每只小鼠由3微克脂多糖(LPS)触发的血清TNF活性。抗SRBC抗体在2周时诱导至最高水平,但获得性免疫并不影响TNF的触发。然而,在初次攻击后9至10周,当血清中仍存在相对较高的抗体滴度时,用每只小鼠10⁸个SRBC进行静脉再次攻击会使LPS触发的TNF活性短暂增强至正常对照小鼠的约10倍。SRBC攻击的这种启动作用具有抗原特异性,因为用马红细胞(HRBC)攻击没有效果。用抗SRBC抗血清处理或超声处理的SRBC调理的SRBC没有效果。这些发现提示了促进内源性TNF产生触发的两种方式:用相应抗原对免疫动物进行加强攻击使其为TNF触发做好准备,以及即使向正常动物直接注射免疫复合物也使其为TNF触发做好准备。讨论了这些发现通过使用免疫复合物在人类癌症患者中诱导内源性TNF产生的可能应用。